Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-230X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV ; volume:20 ; number:1 ; day:13 ; month:7 ; year:2020 ; pages:1-9 ; date:12.2020
BMC gastroenterology ; 20, Heft 1 (13.7.2020), 1-9, 12.2020

Urheber
Maponga, Tongai Gibson
Glashoff, Richard H.
Vermeulen, Hannali
Robertson, Barbara
Burmeister, Sean
Bernon, Marc
Omoshoro-Jones, Jones
Ruff, Paul
Neugut, Alfred I.
Jacobson, Judith S.
Preiser, Wolfgang
Andersson, Monique I.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12876-020-01372-2
URN
urn:nbn:de:101:1-2020091001091929337894
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:47 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Maponga, Tongai Gibson
  • Glashoff, Richard H.
  • Vermeulen, Hannali
  • Robertson, Barbara
  • Burmeister, Sean
  • Bernon, Marc
  • Omoshoro-Jones, Jones
  • Ruff, Paul
  • Neugut, Alfred I.
  • Jacobson, Judith S.
  • Preiser, Wolfgang
  • Andersson, Monique I.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma

Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma

Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway

Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway

SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma

SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma

Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression

Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression

Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression

Arginine methylation of HSPA8 by PRMT9 inhibits ferroptosis to accelerate hepatitis B virus-associated hepatocellular carcinoma progression

Hepatitis C virus-associated pruritus : Etiopathogenesis and therapeutic strategies

Hepatitis C virus-associated pruritus : Etiopathogenesis and therapeutic strategies

Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis

Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma

Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients

Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients

Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation

Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis

Verbundene Objekte